EDAX quantitation of phosphorus is an objective biomarker for psoriatic disease activity and treatment response
DOI:
https://doi.org/10.46570/utjms-2026-1898Keywords:
psoriasis, phosphorus, objective testing, energy dispersive x ray microanalysis, electron transmission microscopyAbstract
Assessing the effectiveness of newer treatments of psoriasis continue to be analyzed by various clinical parameters. Such evaluations include psoriasis area and severity index (PAPS), body surface area (BSA), dermatology life quality index (DLQI), physician's global assessment (PGA), self-administered PASI (SAPASI), and psoriasis epidemiology screening tool (PEST). Of note, there are few objective tests for use in determining treatment response with psoriasis. Of all the objective tests discussed, energy dispersive x-ray microanalysis quantitates and localizes the element to the tissue studied and moreover could act as an objective test to act as a biomarker for psoriatic activity and treatment response.
References
Berg JM, Tymoczko JL, Stryer L. Biochemistry. 7th ed. W.H. Freeman; 2012.
Nicholls DG, Ferguson SJ. Bioenergetics 4. Academic Press; 2013.
Van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9:112?124.
Cohen P. The role of protein phosphorylation in human health and disease. Eur J Biochem. 2001;268:5001?5010.
Hunter T. Signaling—2000 and beyond. Cell. 2000;100:113?127.
Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis. J Invest Dermatol. 2013;133:377?385.
Koo J, Lebwohl M. Phosphorylase kinase inhibition in psoriasis. J Dermatolog Treat. 1999;10:3?10.
Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007;25:535?546.
Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496?509.
Wong R, Geyer S, Weninger W, Guimberteau JC, Wong JK. The dynamic anatomy and patterning of skin. Exp Dermatol. 2016;25:92?98.
Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157:238?244.
Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis. JAMA. 2020;323:1945?1960.
Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis. J Autoimmun. 2015;64:66?73.
Nair RP, Stuart PE, Nistor I, et al. HLA?C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78:827?851.
Ghoreschi K, Laurence A, O’Shea JJ. Janus kinases in immune cell signaling. Immunity. 2009;31:611?621.
Checa A, Aranda F, Mayoral M, et al. Sphingolipid metabolism is dysregulated in psoriasis. J Invest Dermatol. 2015;135:1601?1609.
Carmeliet P. Angiogenesis in life, disease, and medicine. Nature. 2005;438:932?936.
Goldstein J, Newbury DE, Echlin P, et al. Scanning Electron Microscopy and X?Ray Microanalysis. Springer; 2003.
Bottomley PA. MR spectroscopy of the human brain. Ann N Y Acad Sci. 1987;508:333?348.
DeCosta A, Nguyen GH, Tran TS, et al. IL?36? immunohistochemistry for psoriasis diagnosis. J Am Acad Dermatol. 2025;93:779?780.
Burkhart CG, Burnham JC. Elevated phosphorus in psoriatic skin by EDAX. J Cutan Pathol. 1983;10:171?177.
Grundin TG, Romans GM, Forslind B, et al. X?ray microanalysis of psoriatic skin. J Invest Dermatol. 1985;85:378?380.
Zemtsov A, Dixon L, Cameron G. Human in vivo phosphorus?31 MRS in psoriasis. J Am Acad Dermatol. 1994;30:959?965.
Tsambaos D, Kalofoutis A, Stratigos J, et al. Phospholipid TLC in psoriatic epidermis. Br J Dermatol. 1977;97:135?138.
de Graaf RA. In Vivo NMR Spectroscopy: Principles and Techniques. Wiley; 2007.
Forslind B. A new look at the skin barrier: EDAX analysis. Acta Derm Venereol. 1994;74:1?6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr. Craig Burkhart, MD, MPH (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

